Grace Sciencellc Is A Biotechnology Company Based In Menlo Parkcaliforniafounded In 2017 By Matt Wilsey And Nobel Laureate Drcarolyn Bertozzithe Company Was Established To Address Ngly1 Deficiencya Rare Genetic Disorder Affecting Matt S Daughtergracegrace Science Has Since Broadened Its Focus To Explore The Ngly1 Pathway For Potential Treatments Across Various Diseasesincluding Oncology And Neurodegeneration The Company Specializes In Drug Discovery And Developmentwith A Lead Drug Candidate For Ngly1 Deficiency And Ongoing Work On Small Molecule Drugs Targeting Cancers Reliant On Ngly1 Inhibitiongrace Science Emphasizes Collaborationspeedand Openness In Its Operationsbringing Together Experts From Diverse Scientific Fields To Prioritize Patient Needswith A Commitment To Innovationthe Company Has Raised $54 Million From Investors Interested In Both Its Social Mission And Financial Potential
